Literature DB >> 30651294

Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.

Philip E Castle1, Vânia R S Silva2, Marcia E L Consolaro2, Nádia Kienen3, Lorna Bittencourt4, Sandra M Pelloso2, Edward E Partridge4, Amanda Pierz5, Camila B Dartibale2, Nelson S Uchimura2, Isabel C Scarinci4.   

Abstract

Most cervical cancers occur in women who do not participate in cervical-cancer screening. We therefore evaluated adherence to screening for clinic-based Pap testing, self-collected sampling for HPV testing, and choice of the 2 among 483 unscreened/underscreened women in Brazil. Three public Basic Health Units (BHU) were each randomly assigned to three arms: (i) Pap testing at the BHU (N = 160), (ii) "Self&amp;HPV" (self-collection for HPV testing) (N = 161), and (iii) "Choice" between self-collection and HPV testing and Pap test at the local BHU (N = 162). The theory-based (PEN-3 and Health Belief Model) intervention in all three arms was implemented by trained Community Health Workers (CHW) at participants' home. With the first invitation, 60.0% in the Pap arm, 95.1% [154 of 161 (95.7%) who selected Self&amp;HPV and 0 of 1 (0.0%) who selected Pap] in the Choice arm, and 100% in the Self&amp;HPV arm completed screening. By the second invitation to choose a method of screening in the Choice arm, 100% completed screening. After three invitations, 75.0% of women in the Pap arm completed screening. Adherence to screening differed by study arm (P < 0.001). In conclusion, Self&amp;HPV testing is a promising strategy for unscreened/underscreened women who are recalcitrant or unable to undergo clinic-based cervical screening to complement the screening modality used in the general population. In Brazil, where Pap testing is recommended for routine cervical screening, training CHWs in behavior change strategies and offering Self&amp;HPV or Choice could greatly improve screening population coverage by reaching the unscreened/underscreened populations. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 30651294      PMCID: PMC7285814          DOI: 10.1158/1940-6207.CAPR-18-0419

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  47 in total

1.  Training Community Health Workers to promote breast cancer screening in Brazil.

Authors:  Lorna Bittencourt; Isabel C Scarinci
Journal:  Health Promot Int       Date:  2019-02-01       Impact factor: 2.483

2.  Randomization by group: a formal analysis.

Authors:  J Cornfield
Journal:  Am J Epidemiol       Date:  1978-08       Impact factor: 4.897

3.  Sowing the Seeds of Health: Training of Community Health Advisors to Promote Breast and Cervical Cancer Screening among Latina Immigrants in Alabama.

Authors:  Isabel C Scarinci; Isabel C Garcés-Palacio; Mercedes M Morales-Alemán; Allison McGuire
Journal:  J Health Care Poor Underserved       Date:  2016

Review 4.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

5.  Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women.

Authors:  S A Lippman; M C A Sucupira; H E Jones; C G Luppi; J Palefsky; J H H M van de Wijgert; R L S Oliveira; R S Diaz
Journal:  Int J STD AIDS       Date:  2010-02       Impact factor: 1.359

6.  Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.

Authors:  Everton F Augusto; Maria L G Rosa; Silvia M B Cavalcanti; Ledy H S Oliveira
Journal:  Arch Gynecol Obstet       Date:  2012-08-12       Impact factor: 2.344

7.  AMIGAS: a multicity, multicomponent cervical cancer prevention trial among Mexican American women.

Authors:  Theresa L Byrd; Katherine M Wilson; Judith Lee Smith; Gloria Coronado; Sally W Vernon; Maria Eugenia Fernandez-Esquer; Beti Thompson; Melchor Ortiz; David Lairson; Maria E Fernandez
Journal:  Cancer       Date:  2012-12-21       Impact factor: 6.860

8.  Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).

Authors:  Richard Taylor; Stephen Morrell; Hassan Mamoon; Gerard Wain; Jayne Ross
Journal:  Cancer Causes Control       Date:  2006-04       Impact factor: 2.506

9.  Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence.

Authors:  Daniel X Yang; Pamela R Soulos; Brigette Davis; Cary P Gross; James B Yu
Journal:  Am J Clin Oncol       Date:  2018-03       Impact factor: 2.339

10.  Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach.

Authors:  Pooja Bansil; Scott Wittet; Jeanette L Lim; Jennifer L Winkler; Proma Paul; Jose Jeronimo
Journal:  BMC Public Health       Date:  2014-06-12       Impact factor: 3.295

View more
  4 in total

1.  High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.

Authors:  Philip E Castle; John E Varallo; Margaret Mary Bertram; Bakgaki Ratshaa; Moses Kitheka; Kereng Rammipi
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

Review 2.  Human Papilloma Virus self-sampling performance in low- and middle-income countries.

Authors:  Ashwini Kamath Mulki; Mellissa Withers
Journal:  BMC Womens Health       Date:  2021-01-06       Impact factor: 2.809

Review 3.  Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination.

Authors:  Flávia M Corrêa; Arn Migowski; Liz M de Almeida; Marcelo A Soares
Journal:  Front Med (Lausanne)       Date:  2022-08-24

4.  Designing an Effective Colorectal Cancer Screening Program in Egypt: A Qualitative Study of Perceptions of Egyptian Primary Care Physicians and Specialists.

Authors:  Lori Brand Bateman; Somaia Khamess; Salah-Eldin Abdelmoneim; Waleed Arafat; Mona N Fouad; Yomna Khamis; Abbas Omar; Randa Salah Abdelmoneim; Isabel Scarinci
Journal:  Oncologist       Date:  2020-02-24       Impact factor: 5.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.